Trial Profile
Glivec in Pediatric Chronic Myeloid Leukemia (CML).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 10 Oct 2016 Status changed from active, no longer recruiting to completed.
- 20 Feb 2009 New trial record